Industry News
- Articles
- New FDA Approval for Lumigan
- Alcon's Travatan Z Solution Receives FDA Approval
- Alcon's Travatan Z and Systane Use Different Preservatives
- Pfizer Sponsors New "All Eyes on Glaucoma" Website
- Discussions
- Re: Alcon's Travatan Z Solution Receives FDA Approval
- Dr. Ghosh,
If you click on the Alcon logo on the lower right side of this website, it will bring you to Alcon's Travatan website where there is complete product information
read more - Re: Alcon's Travatan Z Solution Receives FDA Approval
- I would like to receive some full text about the new approved drug Travatan Z
Clinical Guidelines
- Articles
- CCT: Is is time to say YES?
- The Role of CCT in Glaucoma Patients
- More CCT
- The Paradox of IOP
- Should We Treat All Ocular Hypertensives?
- Beta Blockers in Glaucoma Management
- Re-Defining Ocular Hypertension
- Implications of Macro-Disc Asymmetry in Glaucoma Suspects
- Nine-Year Changes in Intraocular Pressure: The Barbadoes Eye Studies
- Discussions
- Re: The Paradox of IOP
- At a recent education event one of our attendees asked me to find out the incidence of ocular hypertension in the general population. I could not identify a study noting
read more
Pharmacology Update
- Articles
- Extravan: Alcon Pharmaceuticals
- Mechanism of IOP Reduction with Travoprost
- Discussions
- Re: Extravan: Alcon Pharmaceuticals
- Extravan has not yet received FDA approval in the U.S. However, Alcon's Travatan/Timolol fixed combination is approved as DuoTrav in Europe, Australia and Canada. It is approved for dosing in
read more - Re: Extravan: Alcon Pharmaceuticals
- Dr. Fisher - I have not used any combo drugs at this time. I have asked Paul Smith from Alcon to post an answer. Let's see what Alcon reports. Thanks
- Re: Extravan: Alcon Pharmaceuticals
- Extravan is QD dosing. Timolol is QAM and Travatan is QHS. When is Extravan used?
In Your Office
- Articles
- Glaucoma Flowsheet
- Tonometer Calibration
- Pachymetry Coding
- BCBS Coverage of SCODI Services
- Expanded Coverage of Glaucoma Screening Services
- Discussions
- Re: Pachymetry Coding
- I think there should be pachymetry codes for keratoconus, pellucid marginal degeneration, Fuch's, and other conditions that may cause the cornea to thin or swell. It is next to impossible
read more
Glaucoma Watch
- Articles
- Interesting Glaucoma Cases
- From Ocular Hypertension to Glaucoma: How to Predict Conversion
- Neckties and IOP: The Controversy Continues
- Introduction to the National Glaucoma Society
- Case Presentation: Optic Nerve Imaging
- NGS Residency Award and Lecture
- Optic Nerve Head Measurements with the HRT III
- Case Presentation: Laser Imaging Detects Early ON Damage
- Is the Optic Disc "Sinking" or "Cupping" in Glaucoma?
- Interview with Dr. Barry Barresi
- The Prevalence of Open-angle Glaucoma Among Blacks and Whites 73 Years and Older
- Altered Nitric Oxide System in Patients with Open-Angle Glaucoma
- Oxidative Stress in Glaucoma: A Burden of Evidence
- Discussions
- Re: Oxidative Stress in Glaucoma: A Burden of Evidence
- This article manifests some interesting insight. So far, we have failed to address the fundamental question: Why (among the one million densely packed nerve fibers in a 1.5 mm sized
read more - Re: Interesting Glaucoma Cases
- Hello,
This has been an interesting discussion with many valid points made. I would like to add two observations.
The concurrent use of Pilo and a prostaglandin is unusual as these
read more - Re: Interesting Glaucoma Cases
- I agree with the all of the options mentioned above with the strong exception of using a potentialy high CCT value as an OK to back off of treatment. The
read more
